The Molecular Mechanisms and Therapeutics in Multiple Sclerosis
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Biological Factors".
Deadline for manuscript submissions: closed (15 July 2021) | Viewed by 19190
Special Issue Editors
Interests: multiple sclerosis; NMOSD; autoimmune encephalitis; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: neuroimmunology; multiple sclerosis; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multiple sclerosis is a neuroinflammatory and neurodegenerative disease and the leading cause of neurological disability in young adults. More than 2 million patients are affected worldwide. In the last two decades, there has been unimaginable progress in treatment. While treatment options for relapsing MS are already well established, treatment options for progressive MS remain limited. The ultimate goal of curing MS has still not been achieved and will not be achievable for the foreseeable future.
The aim of this thematic collection of Biomolecules is to highlight recent findings in pathophysiology, histopathology, and their translation into therapeutic concepts. We encourage contributions on the latest immunological and pathophysiological findings, latest therapeutic concepts with special focus on progressive courses, and future therapeutic options. Studies dealing with biomarkers, in diagnostic and prognostic but also therapeutic areas, are also of particular interest.
Prof. Dr. Paulus Stefan Rommer
Prof. Dr. Uwe Klaus Zettl
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Histopathology in MS
- innate and adaptive immunity
- autoimmunity
- relapsing and progressive MS
- Treatment options in MS
- Biomarkers in MS
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.